European Gateway

BioBusiness  –  December 2009/January 2010

 

By Bernadette Johnson

Significant investments from government, industry and academia over the last several years have turned the Netherlands into a hotbed of life sciences innovation, with emphasis on biomed and healthcare applications.

The executive editor of this Canadian publication explores the reasons why the Dutch are attracting more foreign investment and providing the ideal European gateway for biotech companies.

For the complete article, please click here.